MGH Center for Women's Mental Health

About MGH Center for Women's Mental Health

This author has not yet filled in any details.
So far MGH Center for Women's Mental Health has created 1457 blog entries.

PPHN and SSRIs: Yet Another Study

A few weeks after the FDA called into question the association between SSRI exposure and persistent pulmonary hypertension of the newborn or PPHN, BMJ published another article supporting an increased risk of PPHN among infants exposed to SSRIs in utero.

By |2015-08-12T16:58:14-04:00January 26th, 2012|Antidepressants, Child Outcomes, Neonatal Symptoms, Outcomes, Pregnancy & Medications|Comments Off on PPHN and SSRIs: Yet Another Study

Depression in Women: Is There a Role for Vitamin D?

Sources of vitamin D include sunlight (ultraviolet B, or UVB, rays), dietary intake, and supplements.  Sunlight is the main source of human vitamin D.  Vitamin D refers to different forms of a steroid hormone.   Vitamin D3 (also called 1, 25-dihydroxycholecalciferol or calcitriol) is produced by the body when ultraviolet light (in the form of UV B) interacts with 7-dehydrocholesterol .  Vitamin D3 is thought to be more potent than vitamin D2, with D3 and D2 being the two forms of vitamin D contained in supplements.

By |2015-08-12T17:00:04-04:00January 24th, 2012|Depressive Disorders, General|Comments Off on Depression in Women: Is There a Role for Vitamin D?

SSRIs and PPHN: The FDA Revises Its Warning

In 2006, Chambers and colleagues published an article in the New England Journal of Medicine linking SSRI use during late pregnancy to an increased risk of persistent pulmonary hypertension in the newborn (PPHN).   Based on these findings, the “Usage in Pregnancy” section on the labels for SRRI antidepressants was updated to include the following warning: “Infants exposed to SSRIs in late pregnancy may have an increased risk for persistent pulmonary hypertension of the newborn (PPHN).”

By |2015-08-12T17:01:20-04:00January 17th, 2012|Antidepressants, Child Outcomes, Neonatal Symptoms, Outcomes, Pregnancy & Medications|Comments Off on SSRIs and PPHN: The FDA Revises Its Warning

Post Traumatic Stress Disorder and Pregnancy

Understanding posttraumatic stress disorder (PTSD) during pregnancy is important given that PTSD is relatively common and persistent in nature.  PTSD will occur in approximately 10% of women in their lifetime, with one-third of episodes lasting more than five years.  Given the relatively high prevalence of PTSD in young women and the chronic nature of the illness, many women may experience PTSD symptoms during pregnancy.

By |2018-07-11T11:02:06-04:00December 20th, 2011|Diagnosis & Screening, Prevalence & Risk Factors, Psychiatric Disorders During Pregnancy, PTSD and Stress Related Disorders|Comments Off on Post Traumatic Stress Disorder and Pregnancy

Clinical Case: Would You Use Gabapentin (Neurontin) During Pregnancy?

Ms. P is a 32-year-old married woman who presented for consultation regarding the use of medication during pregnancy.  She had been taking fluoxetine (Prozac) 20 mg for many years for the treatment of recurrent major depression and generalized anxiety.  In addition, she was prescribed gabapentin (Neurontin) for sleep.

By |2015-08-12T17:04:26-04:00December 13th, 2011|Pregnancy & Medications|Comments Off on Clinical Case: Would You Use Gabapentin (Neurontin) During Pregnancy?

Escitalopram (Lexapro) and Pregnancy

Both citalopram and escitalopram are antidepressants belonging to the SSRI class.  While escitalopram (marketed in the U.S. as Lexapro) contains only the S-stereoisomer (or enantiomer) of the drug citalopram, Celexa or generic citalopram is a racemic mixture of the S-citalopram and its mirror image, R-citalopram, which is less effective as an antidepressant.

By |2015-08-12T17:07:37-04:00December 5th, 2011|Antidepressants, Outcomes, Pregnancy & Medications|Comments Off on Escitalopram (Lexapro) and Pregnancy

Light Therapy: A Good Alternative to Medications during Pregnancy?

Depression during pregnancy is common and has major health implications for the mother, the fetus and the family.  On this website, we have reviewed numerous treatments for affective disorders in pregnancy, including psychotropic medications and several forms of psychotherapy.  We have not had much data to support the use of light therapy for antepartum depression, yet I often discuss light therapy as a potential adjunctive treatment for patients with a seasonal component to their depression.  A recent study, published by Wirz-Justice and colleagues in the Journal of Clinical Psychiatry, provides evidence that light therapy may be a useful non-pharmacologic treatment for women who suffer from depression during pregnancy(1).

By |2024-07-24T11:56:34-04:00October 20th, 2011|Alternative & Complementary, Depressive Disorders, Psychiatric Disorders During Pregnancy, Treatment|Comments Off on Light Therapy: A Good Alternative to Medications during Pregnancy?
Go to Top